MedTrace Logo

Sweetheart-Register: Risk Management of Diabetics with Acute Myocardial Infarction

NCT01197742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2772

Last updated 2024-12-20

No results posted yet for this study

Summary

The Sweetheart register (Risk management of Diabetics with acute myocardial infarction) documents both the prevalence of pathologic glucose metabolism in consecutive high-risk patients with STEMI and NSTEMI in daily hospital routine as well as the anti-diabetic acute and long-term therapy. Furthermore the register will provide data about the implementation of new guidelines for the interventional and adjuvant medical therapy of STEMI and NSTEMI.

Conditions

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Anselm K Gitt, MD · Stiftung Institut für Herzinfarktforschung

  • Jochen Senges, MD · Stiftung Institut für Herzinfarktforschung

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-20
Primary Completion
2009-10-05
Completion
2009-10-05

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197742 on ClinicalTrials.gov